<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://business.gourt.com/Business-Services/Consulting/Medical-and-Life-Sciences.html">
<title>Medical_and_Life_Sciences RSS : Gourt</title>
<link>http://business.gourt.com/Business-Services/Consulting/Medical-and-Life-Sciences.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2008-10-06T04:31+51:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Medical_and_Life_Sciences RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Insurance_QIS3toQIS4consultationtoimplementation_SV_22September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Assurance_SECIssuesIFRSRoadmapHotTopic_MR_091508&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_SupplierDiversity_TheresaHarrison40UnderForty_MR_091508&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_AboutUs_BethBrookeForbesMostPowerful_MR_091508&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Tax_MarkWeinbergerSpeechTaxLandscape_MR_091508&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Assurance_GoodwillLongLivedAssetsTCW_MR_091508&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_TP_BRICSupplyChainBrazilRussia_TCWebcastPart2_MR_091508&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Webcast_conversion_considerations_IFRS_JJ_12September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_BCM_IFRS_conference_highlights_JJ_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_PrivateEquity_Private_Equity_Leadership_Network_JJ_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Insurance_SolvencyII_Internal_Model_Architecture_NC_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Real_Estate_Webcast_conversion_considerations_for_IFRS_NC_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Tax_HC_Accidental_expatriates_other_short-term_global_travelers_webcast_NC_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Real_Estate_IFRS_real_estate_insights_NC_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_TAS_Navigating_the_credit_crunch_webcast_NC_10September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Media_Quality_of_property_catastrophe_NC_09September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://int.sitestat.com/ernst-and-young/us/s?RSS_Oil_and_Gas_National_oil_company_monitor_Q2_NC_09September2008&#x26;ns_type=clickin" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6883c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6923c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6922c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6915c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6912c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6901c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6914c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6905c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6904c&#x26;src=RSS&#x26;type=link" />
  <rdf:li rdf:resource="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6907c&#x26;src=RSS&#x26;type=link" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Insurance_QIS3toQIS4consultationtoimplementation_SV_22September2008&#x26;ns_type=clickin">
<title>QIS 3 to QIS 4: from consultation to implementation</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Insurance_QIS3toQIS4consultationtoimplementation_SV_22September2008&#x26;ns_type=clickin</link>
<description><![CDATA[The Committee of European Insurance and Occupational Pensions Supervisors (CEIOPS) is involving the insurance industry in a multi-year consultation process to test proposed Solvency II regulations. These Quantitative Impact Studies (QIS), performed by companies on a volunteer basis, test the design and calibration of the future European Standard formula.]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Assurance_SECIssuesIFRSRoadmapHotTopic_MR_091508&#x26;ns_type=clickin">
<title>SEC issues IFRS &#x22;Roadmap&#x22; </title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Assurance_SECIssuesIFRSRoadmapHotTopic_MR_091508&#x26;ns_type=clickin</link>
<description><![CDATA[On 27 August the SEC approved for public comment a proposed "Roadmap" about the eventual use of IFRS by US companies. It anticipates mandatory reporting in 2014, 2015 or 2016, depending on the size of the issuer, and provides for early adoption in some cases. This Hot Topic summarizes the most significant aspects of the proposed Roadmap, based on comments made at the SEC's public meeting.]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_SupplierDiversity_TheresaHarrison40UnderForty_MR_091508&#x26;ns_type=clickin">
<title>Theresa Harrison is Named to &#x3C;em&#x3E;Network Journal&#x3C;/em&#x3E;&#x2019;s &#x22;40 Under Forty&#x22;</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_SupplierDiversity_TheresaHarrison40UnderForty_MR_091508&#x26;ns_type=clickin</link>
<description><![CDATA[Theresa Harrison, Director of Supplier Diversity, is one of this year's "40 Under Forty Dynamic Achievers,” according to Network Journal magazine. Co-chair of our Professional Women's Network, Theresa was honored for her career accomplishments and her commitment to her community. In addition to providing opportunities for diverse business owners, Theresa volunteers with the Selective Corporate Internship Program, which exposes talented high school juniors to prospective corporate careers. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_AboutUs_BethBrookeForbesMostPowerful_MR_091508&#x26;ns_type=clickin">
<title>Beth Brooke named one of world&#x2019;s &#x27;100 Most Powerful Women&#x27; for the third year in a row </title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_AboutUs_BethBrookeForbesMostPowerful_MR_091508&#x26;ns_type=clickin</link>
<description><![CDATA[For the third consecutive year, Forbes magazine has named Beth Brooke, Ernst & Young Global Vice Chair of Public Policy, Sustainability and Stakeholder Engagement, to its prestigious list of the World’s 100 Most Powerful Women. Beth “balances a politician's passion with the scrupulous eye of a CPA,” Forbes noted.]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Tax_MarkWeinbergerSpeechTaxLandscape_MR_091508&#x26;ns_type=clickin">
<title>The transformation of the tax landscape</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Tax_MarkWeinbergerSpeechTaxLandscape_MR_091508&#x26;ns_type=clickin</link>
<description><![CDATA[Four change engines are reshaping how tax professionals operate and think about their roles, according to Mark Weinberger, Global Vice Chair of Tax. Globalization, a new tax audit paradigm, a shifting economy and impending legislative and regulatory developments bring extraordinary challenges and opportunities. Read Mark’s speech published in Tax Notes.]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Assurance_GoodwillLongLivedAssetsTCW_MR_091508&#x26;ns_type=clickin">
<title>Webcast: Goodwill and long-lived assets in an IFRS world </title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Assurance_GoodwillLongLivedAssetsTCW_MR_091508&#x26;ns_type=clickin</link>
<description><![CDATA[Despite similarities between IFRS and US GAAP for accounting and impairment of long-lived assets, differences still exist. They are notable in   the way impairment is reviewed, recognized and measured. We invite you to attend our IFRS webcast on 19 September so you can learn how to reduce risk and manage changes specific to recognition and impairment of goodwill, long-lived assets and intangibles. 
 ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_TP_BRICSupplyChainBrazilRussia_TCWebcastPart2_MR_091508&#x26;ns_type=clickin">
<title>Keys to tax-effective supply chain management in BRIC </title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_TP_BRICSupplyChainBrazilRussia_TCWebcastPart2_MR_091508&#x26;ns_type=clickin</link>
<description><![CDATA[Brazil, Russia, India and China (BRIC) present unique challenges for supply chain leaders and international tax planners. We invite you to join our two-part Thought Center Webcast series where our international panel discusses the issues affecting supply chain management in the BRIC countries and alternative structures that are seen in practice.  Register for the September 18  Brazil and Russia webcast. If you missed the September 11 India and China webcast, stay tuned for the archive.]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Webcast_conversion_considerations_IFRS_JJ_12September2008&#x26;ns_type=clickin">
<title>Webcast: conversion considerations for IFRS</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Webcast_conversion_considerations_IFRS_JJ_12September2008&#x26;ns_type=clickin</link>
<description><![CDATA[A transition to IFRS may be here faster than you think. Its impact on business operations throughout the automotive industry will be the focus of an upcoming webcast on Monday, 29 September at 11:00am ET. The Ernst & Young Global Automotive Center invites you to register for our upcoming webcast so that you can learn about its potential impact on the industry. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_BCM_IFRS_conference_highlights_JJ_10September2008&#x26;ns_type=clickin">
<title>IFRS in the spotlight: preparing for the move</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_BCM_IFRS_conference_highlights_JJ_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[Are you ready for IFRS? That question was the main theme last May when regulators, financial services companies, business leaders, accountants and others converged in New York for Ernst & Young’s daylong IFRS preparedness conference. Read on for the highlights. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_PrivateEquity_Private_Equity_Leadership_Network_JJ_10September2008&#x26;ns_type=clickin">
<title>Engaging the talents of senior non-deal professionals</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_PrivateEquity_Private_Equity_Leadership_Network_JJ_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[The July 2008 meeting of the Private Equity Leadership Network focused on PE’s growing use of senior non-deal professionals to manage their organizations and interface with external stakeholders. Members also had a wide-ranging discussion of current market conditions. The August 2008 issue of ViewPoints, from Ernst & Young and Tapestry Networks, summarizes their dialogue. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Insurance_SolvencyII_Internal_Model_Architecture_NC_10September2008&#x26;ns_type=clickin">
<title>Five steps to optimizing Solvency II internal model architecture</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Insurance_SolvencyII_Internal_Model_Architecture_NC_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[For long-term success in meeting the requirements of Solvency II, it’s essential that insurers keep an eye on the future when designing the framework and processes around the internal model architecture. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Real_Estate_Webcast_conversion_considerations_for_IFRS_NC_10September2008&#x26;ns_type=clickin">
<title>Webcast: conversion considerations for IFRS</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Real_Estate_Webcast_conversion_considerations_for_IFRS_NC_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[A transition to IFRS may be here faster than you think. Its impact on business operations throughout the real estate industry will be the focus of an upcoming webcast on Tuesday, 16 September at 1:00pm ET. The Ernst & Young Global Real Estate Center invites you to register for our upcoming webcast so that you can learn how to prepare for the implementation now.]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Tax_HC_Accidental_expatriates_other_short-term_global_travelers_webcast_NC_10September2008&#x26;ns_type=clickin">
<title>Thought Center Webcast: accidental expatriates and other short-term global travelers</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Tax_HC_Accidental_expatriates_other_short-term_global_travelers_webcast_NC_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[On August 4 2008, Ernst & Young held a Thought Center Webcast with Human Capital and International Tax professional which tackled the most timely and relevant issues for companies who have accidental expatriates and short-term business travelers. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Real_Estate_IFRS_real_estate_insights_NC_10September2008&#x26;ns_type=clickin">
<title>IFRS real estate insights</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Real_Estate_IFRS_real_estate_insights_NC_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[From looking at implementation issues, to understanding the differences between US GAAP and IFRS, or gaining insights into key issues real estate organizations should consider as they evaluate potential conversion to IFRS, we are pleased to offer practical guidance and up-to-date knowledge on this financial reporting language. Learn about the requirements of IFRS specific to the real estate industry from our various thought leadership reports. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_TAS_Navigating_the_credit_crunch_webcast_NC_10September2008&#x26;ns_type=clickin">
<title>Register for our webcast: navigating the credit crunch</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_TAS_Navigating_the_credit_crunch_webcast_NC_10September2008&#x26;ns_type=clickin</link>
<description><![CDATA[One key finding in our latest PE study revealed that the largest private equity-owned businesses continued to outperform public company benchmarks. It also suggests PE business models would continue to propel value for portfolio companies as firms navigate the credit crunch. Discover how these ground-breaking study results are likely to affect PE firms going forward in our upcoming webcast on 10 September at 12:00pm ET. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Media_Quality_of_property_catastrophe_NC_09September2008&#x26;ns_type=clickin">
<title>Quality of property catastrophe data impacts reinsurance pricing</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Media_Quality_of_property_catastrophe_NC_09September2008&#x26;ns_type=clickin</link>
<description><![CDATA[When it comes to their ability to underwrite property catastrophe exposure, the biggest concern among reinsurers is quality of cedant data, according to Ernst & Young LLP’s 2008 Catastrophe Exposure Data Quality Survey. In fact, the study found data quality can directly impact reinsurance pricing and capacity extension. ]]></description>
</item>

<item rdf:about="http://int.sitestat.com/ernst-and-young/us/s?RSS_Oil_and_Gas_National_oil_company_monitor_Q2_NC_09September2008&#x26;ns_type=clickin">
<title>National oil company monitor Q2 2008</title>
<link>http://int.sitestat.com/ernst-and-young/us/s?RSS_Oil_and_Gas_National_oil_company_monitor_Q2_NC_09September2008&#x26;ns_type=clickin</link>
<description><![CDATA[NOCs are not only becoming more international in nature, but also more integrated, investing in refining and petrochemicals both at home and abroad. In this edition, we explore the most common strategic drivers of the pursuit of an increased downstream presence by NOCs, examine new foreign partnerships and alliances, and analyze government policy developments taking place across the globe. ]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6883c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Venosan North America</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6883c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Venosan North America on 21 Nov 2007 by Center for Devices and Radiological Health]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6923c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Ranbaxy Laboratories, Ltd., Dewas, India</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6923c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Ranbaxy Laboratories, Ltd., Dewas, India on 16 Sep 2008 by Center for Drug Evaluation and Research]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6922c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Ranbaxy Laboratories, Ltd., Paonta Sahib, India</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6922c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Ranbaxy Laboratories, Ltd., Paonta Sahib, India on 16 Sep 2008 by Center for Drug Evaluation and Research]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6915c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Drs. Foster and Smith, Inc.</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6915c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Drs. Foster and Smith, Inc. on 05 Sep 2008 by Minneapolis District Office]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6912c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to White, Rodney A., M.D.</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6912c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to White, Rodney A., M.D. on 05 Sep 2008 by Center for Devices and Radiological Health]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6901c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Gardiziola, Gregory, D.O.</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6901c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Gardiziola, Gregory, D.O. on 03 Sep 2008 by Center for Drug Evaluation and Research]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6914c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Shrock, John E.</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6914c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Shrock, John E. on 03 Sep 2008 by Cincinnati District Office]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6905c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Roselife, LLC</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6905c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Roselife, LLC on 02 Sep 2008 by Detroit District Office]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6904c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Jerusalem Manufacturing Nature Foods &#x26; Wholesalers, Inc.</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6904c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Jerusalem Manufacturing Nature Foods & Wholesalers, Inc. on 02 Sep 2008 by Detroit District Office]]></description>
</item>

<item rdf:about="http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6907c&#x26;src=RSS&#x26;type=link">
<title>WL Issued to Hamilton Medical Center</title>
<link>http://www.ComplianceFDA.com/ShowExternHTML.asp?F=CFDAs6907c&#x26;src=RSS&#x26;type=link</link>
<description><![CDATA[FDA Warning Letter Issued to Hamilton Medical Center on 02 Sep 2008 by Center for Devices and Radiological Health]]></description>
</item>

</rdf:RDF>